Clinical trial

T790M Mutation Testing in Blood by Different Methodologies

NCT03363139

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-03-01

PhaseN/A

Study timeline

Study start (actual)2018-03-01Date precision: day

Registry last updated2020-04-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLC Stage IVunresolved

Interventions

Tirosin Kinase InhibitorsDRUG

Sponsors & collaborators

Spanish Lung Cancer Grouplead sponsor

Mapped research locations

ValenciaSpain4 MadridSpain3 BarcelonaSpain2 SevilleSpain1 MálagaSpain1 AlicanteSpain1 GranadaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03363139 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.